[Bcl-2 is an independent predictor of breast cancer outcome and seems to be useful as a prognostic adjunct to the Nottingham Prognostic Index (NPI), particularly in the first 5 years after diagnosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
Gene-disease associations inferred from text-mining the literature.
DisGeNET evidence - LITERATURE